Ethical and Biosafety Oversight of New Car T-Cell Products

May 2, 2019

(GEN) – The rapidly developing field of synthetic biology—including the subfield of synthetic immunology—is putting a plethora of new tools into the hands of basic and translational scientists and enabling new technologies that are transforming molecular biology and medicine. Chimeric antigen receptor (CAR) T-cell technology is a shining example of the promise of using synthetic immunology to enhance human health.

Recommended Reading